Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04291664
Title PK and Dose Escalation and Expansion Study of DST-2970
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors DisperSol Technologies, LLC
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisone

DST-2970 + Prednisone

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.